Intestinal Transplantation With Alemtuzumab (Campath-1H) Induction for Adult Patients

Transplantation Proceedings

Volumn 38, Issue 6, 2006, Pages 1747-1749

  Nishida, S ^a   Levi, D M ^a   Moon, J I ^a   Madariaga, J R ^a   Kato, T ^a   Selvaggi, G ^a   Tryphonopoulos, P ^a   DeFaria, W ^a   Santiago, S ^a   Gaynor, J ^a   Weppler, D ^a   Martinez, E ^b   Ruiz, P ^b   Tzakis, A G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; IMMUNOSUPPRESSIVE AGENT; OKT 3; STEROID; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINES; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33746867891     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.05.057     Document Type: Article

References (6)

1. Calne R., Friend P., Moffatt S., et al. Prope tolerance, perioperative Campath 1H, and low-dose cyclosporine monotherapy in renal allograft recipients. Lancet 351 (1998) 1701
2. Calne R. Almost tolerance in the clinic. Transplant Proc 30 (1998) 3846
3. Nishida S., Levi D., Kato T., et al. Induction therapy for adult small bowel transplant with Campath-1H. Transplant Proc 34 (2002) 1889
4. Tzakis A.G., Kato T., Nishida S., et al. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation 75 (2003) 1512
5. Tryphonopoulos P., Madariaga J.R., Kato S., et al. The impact of Campath 1H induction in adult liver allotransplantation. Transplant Proc 37 (2005) 1203
6. Tzakis A.G., Tryphonopoulos P., Kato T., et al. Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation 77 (2004) 1209